MASSACHUSETTS GENERAL HOSPITAL
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1811-01-01
- Employees
- -
- Market Cap
- -
Advanced MRI Applications Development
- Conditions
- Brain Tumors
- Interventions
- Other: MRI scan
- First Posted Date
- 2013-05-07
- Last Posted Date
- 2018-03-26
- Lead Sponsor
- Massachusetts General Hospital
- Registration Number
- NCT01847833
- Locations
- 🇺🇸
MGH, Boston, Massachusetts, United States
Tivozanib for Recurrent Glioblastoma
- First Posted Date
- 2013-05-03
- Last Posted Date
- 2019-01-08
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 10
- Registration Number
- NCT01846871
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
Memantine Monotherapy for Executive Dysfunction and ADHD
Not Applicable
Withdrawn
- Conditions
- ADHDExecutive Function Deficits (EFD's)
- Interventions
- Drug: Placebo
- First Posted Date
- 2013-05-01
- Last Posted Date
- 2013-09-24
- Lead Sponsor
- Massachusetts General Hospital
- Registration Number
- NCT01844427
Sulindac for Patients With AML
- First Posted Date
- 2013-04-30
- Last Posted Date
- 2017-02-17
- Lead Sponsor
- Massachusetts General Hospital
- Registration Number
- NCT01843179
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
Utility of Novel BRAF Test for Melanoma
- Conditions
- Melanoma
- First Posted Date
- 2013-04-25
- Last Posted Date
- 2021-10-29
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 220
- Registration Number
- NCT01840527
- Locations
- 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
🇺🇸Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸Dana-Farber Cancer Institute, Boston, Massachusetts, United States
Evaluation of PET/MRI in Children with Cancer
Not Applicable
Completed
- Conditions
- Hematologic Malignancy
- Interventions
- Procedure: PET-MRIProcedure: PET-CT
- First Posted Date
- 2013-04-25
- Last Posted Date
- 2025-02-17
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 8
- Registration Number
- NCT01839747
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
Audio-enhanced Analgesia in Healthy Subjects
Not Applicable
Completed
- Conditions
- Healthy
- Interventions
- Behavioral: Enhanced AudioBehavioral: Audio
- First Posted Date
- 2013-04-18
- Last Posted Date
- 2016-03-14
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 60
- Registration Number
- NCT01835275
- Locations
- 🇺🇸
Department of Psychiatry, Mass General Hospital, Charlestown, Massachusetts, United States
The Summer Camp Study: Blood Glucose Control With a Bi-Hormonal Bionic Endocrine Pancreas
Not Applicable
Completed
- Conditions
- Type 1 Diabetes
- Interventions
- Other: Usual CareDevice: Bi-hormonal Bionic Pancreas
- First Posted Date
- 2013-04-17
- Last Posted Date
- 2017-09-08
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 32
- Registration Number
- NCT01833988
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
Brentuximab Vedotin + Re-induction Chemotherapy for AML
Phase 1
Completed
- Conditions
- Acute Myelogenous Leukemia
- Interventions
- First Posted Date
- 2013-04-12
- Last Posted Date
- 2020-04-14
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 22
- Registration Number
- NCT01830777
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
Comparison of Ticagrelor Versus Clopidogrel on Residual Thrombus Burden During PCI: an OCT Study
Phase 4
Withdrawn
- Conditions
- Acute Coronary SyndromeCoronary Artery Disease
- Interventions
- First Posted Date
- 2013-04-08
- Last Posted Date
- 2016-12-20
- Lead Sponsor
- Massachusetts General Hospital
- Registration Number
- NCT01826175
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
© Copyright 2025. All Rights Reserved by MedPath